Learn how we collaborated with Alexion Pharmaceuticals to develop a QSP model which assesses a Lipid Nanoparticle to treat Crigler‐Najjar Syndrome Type 1 and to support translation from preclinical to clinical trials. View the webinar at: hubs.li/H0TmFk70
0
0
1
0
0